NCT00641212View on ClinicalTrials.gov

Children, Perennial Allergic Rhinitis (PAR), l-t Growth

PHASE4CompletedINTERVENTIONAL

Enrollment

209

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions

Perennial Allergic Rhinitis

Interventions

DRUG

Budesonide

DRUG

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY